Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA review of Myotrophin continues after resubmission

Nov. 12, 1997

New neuroprotectants disclosed by Nippon Shinyaku

Nov. 12, 1997

Atypical antipsychotic developed at Esteve characterized

Nov. 11, 1997

Azolobenzazepines claimed by Zeneca for use in stroke

Nov. 11, 1997

Fujisawa reports heterocyclic glutamate receptor antagonists

Nov. 11, 1997

Neurogen describes dopamine receptor subtype-specific ligands

Nov. 11, 1997

Phase Ia study with NGD-91-2 completed

Nov. 10, 1997

Prionics develops antibody useful for diagnosing and possibly treating prion diseases

Nov. 10, 1997

Quinoxalinediones for neurodegenerative/neurological disorders patented

Nov. 10, 1997

Takeda describes new melatonin agonists

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...